Institutional Biosafety Committee

During the current COVID-19 emergency, the Research Compliance staff are working remotely, and in the office,  and are available to discuss issues associated with applications submitted  to IBC and any other business relating to the IBC.

Please contact individual staff through email.

Please contact the IBC Coordinator, Tracee Wilson ( ), IBC Chairperson, Dr. Greg Colores ( or Director of Research Compliance, Dr. Robert Bienkowski ( ) to verify that you may continue your research activities. 

Institutional Biosafety Committee Operations 

Central Michigan University requires registration of all biohazardous research and teaching activities with the Institutional Biosafety Committee. In addition to activities covered by the NIH Guidelines for research involving recombinant or synthetic nucleic acid molecules additional covered categories include:

1. Agents infectious to humans and other animals.

2. Use of human tissues, fluids, or cell lines.

3. Lab or field work on animals for which a documented and reasonable potential for transmission of zoonotic agents exists, e.g., wild-trapped rodents, birds, amphibians.

4. Lab or field work with the intent to isolate or culture pathogens.

5. Research on biological agents that produce harmful toxins, where there is significant potential for human exposure.

6. Research involving nanotechnology or other emerging technology that presents a potential hazard/biohazard. 

Updated 8/18/2020

Report a Research Concern